Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Aphasia
- Propranolol in Primary Progressive Aphasia
- Nabilone for Agitation in Frontotemporal Dementia
- Dopaminergic Therapy for Frontotemporal Dementia Patients
- Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke Aphasia
- Escitalopram and Language Intervention for Subacute Aphasia
- BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES
- The Effect of Venlafaxine on Language Function in Patients With Subcortical Aphasia: A fMRI Study
- Use of Local Intraoperative Steroid in MIS TLIF
- Tau PET Imaging in Atypical Dementias
- A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
- Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study
- Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia
- Tau Imaging in Young Onset Dementia
- Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
- Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
- PiB PET Scanning in Speech and Language Based Dementias
- Augmenting Language Therapy for Aphasia: Levodopa
- Galantamine Treatment for Nonfluent Aphasia in Stroke Patients
- Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
- Effect of Dopaminergic Medication on Recovery of Aphasia
- Memantine and Intensive Speech-Language Therapy in Aphasia
- Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
- Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled Trial
- Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial
- Dopaminergic Enhancement of Learning and Memory in Aphasia